Resultados de búsqueda - (((ligur OR like) OR (((liran OR liran) OR (linan OR ligando)) OR (liga OR lima))) OR migue) 1~

  1. 161
  2. 162
  3. 163
  4. 164
  5. 165
  6. 166

    Values, preferences and burden of treatment for the initiation of GLP-1 receptor agonists and SGLT-2 inhibitors in adult patients with type 2 diabetes: a systematic review por González González, José Gerardo, Díaz González Colmenero, Alejandro, Millán Alanís, Juan Manuel, Lytvyn, Lyubov, Solís, Ricardo Cesar, Mustafa, Reem A, Palmer, Suetonia C, Li, Sheyu, Hao, Qiukui, Alvarez Villalobos, Neri Alejandro, Vandvik, Per Olav, Rodríguez Gutiérrez, René

    “…Objectives Assess values, preferences and burden of treatment that patients with type 2 diabetes consider when initiating glucagon-like peptide-1 receptor agonists (GLP-1 RA) or sodium-glucose cotransporter-2 inhibitors (SGLT-2i) compared with other glucose-lowering options.Methods Paired reviewers independently included studies reporting quantitative or qualitative methods to assess values, preferences and burden of treatment reported by patients with type 2 diabetes regarding the initiation of GLP-1 RA or SGLT-2i over other alternatives. …”
    Enlace del recurso
    Artículo
  7. 167
  8. 168
  9. 169
  10. 170
  11. 171
  12. 172
  13. 173
  14. 174
  15. 175
  16. 176
  17. 177
  18. 178
  19. 179
  20. 180

Herramientas de búsqueda: